Roche announced the launch of the cobas® pulse system in select countries accepting the CE Mark. The cobas® pulse system marks Roche Diagnostics' newest generation of connected point of care solutions for professional blood glucose management. As an industry first, the cobas® pulse system combines the form factor of a high-performance blood glucose meter with simple usability and expanded digital capabilities similar to that of a smartphone.

Glucose is among the most important biomarkers to assess patient health and predict, diagnose and manage metabolic disorders. In particular, the management of blood glucose in patients is critical to preventing acute and chronic complications that may lead to increased morbidity, mortality and healthcare costs. Against the backdrop of a rising epidemic of diabetes and other non-communicable diseases, the need to regularly perform this critical intervention adds to an ever-growing list of responsibilities facing stretched healthcare systems and professionals.

Designed for professional use in a range of care settings where timely and informed clinical decisions are needed, the cobas® pulse system introduces several advancements that aim to drastically simplify workflows for busy nurses and doctors and improve their ability to deliver care at the bedside.